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Abstract 
Emergent hypermucoviscosity (HMV) phenotypes of Klebsiella pneumoniae have been associated with increased 
invasiveness and pathogenicity in primates. In this study, we investigated the interaction of African green monkeys 
(AGM) (Chlorocebus aethiops sabaeus) complement and antibody with HMV and non-HMV isolates as in vitro models 
of primate infection. Significantly greater survival of HMV isolates was evident after incubation in normal serum or 
whole blood (p < 0.05) of AGM donors when compared to non-HMV strains. Greater survival of HMV strains (p < 0.05) 
was found after incubation in whole blood and serum from seropositive donors when compared to seronegative 
donor samples. Additionally, significantly greater amounts of K. pneumoniae were phagocytozed by AGM leukocytes 
when complement was active (p < 0.05), but no difference in uptake was observed when serum from seropositive or 
seronegative animals was used in challenged cells utilizing flow cytometry. Results demonstrate that interaction of 
cellular and humoral immune elements play a role in the in vitro killing of K. pneumoniae, particularly HMV isolates. 
Neither AGM serum, nor washed whole blood effectively killed HMV isolates; however, assays using heparinized whole 
blood of seronegative donors significantly reduced viability of HMV and non-HMV strains. The lack of bacterial killing 
observed in seropositive donors treatments could be at least partially associated with low IgG2 present in these ani-
mals. A better understanding of the pathogenesis of klebsiellosis in primates and host immune response is necessary 
to identify surface molecules that can induce both opsonizing and bactericidal antibody facilitating killing of Kleb-
siella, and the development of vaccines in human and animals.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Klebsiella pneumoniae is a Gram-negative bacte-
rium member of the family Enterobactericeae typically 
found in the environment and on mucosal surfaces. In 
both human and veterinary medicine this bacterium is 
regarded as an emergent and common nosocomial path-
ogen associated with a range of infections [1–6].
A novel, invasive form of K. pneumoniae, referred to as 
hypervirulent and typically presenting a hypermucovis-
cous (HMV) phenotype, has emerged over the last two 
decades [7–10]. Distinct capsular components and an 
increased amount of capsular material in HMV K. pneu-
moniae have been described. The HMV strains have been 
associated with serotypes K1–K6 in humans, non-human 
primates, and marine mammals, and have been associ-
ated more frequently with osteomyelitis, endophthalmi-
tis, meningitis, severe respiratory infection related with 
suppurative pneumonia, pleuritis, and multi systemic 
abscesses in the lung, liver, cervix, brain and septicemia; 
however lack of specific clinical presentation in kleb-
siellosis makes premorbid diagnosis difficult [5, 11–14]. 
Additionally, HMV isolates are associated with several 
virulence genes including rmpA (regulator of mucoid 
phenotype) and magA (mucoviscosity-associated) [7, 15]. 
The magA gene encodes a 43-kD outer membrane pro-
tein, whereas the rmpA gene is a transcriptional activator 
of colanic acid biosynthesis [16].
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Although K. pneumoniae has been recognized as an 
important nosocomial infection, and HMV isolates are 
often associated with high morbidity and mortality in a 
wide range of mammals, the pathogenesis of the disease 
and the epizootiology of the pathogen remain poorly 
characterized. Additionally, little work elucidating the 
role of the HMV phenotype in K. pneumoniae patho-
genicity exists, no vaccines are available, and few studies 
provide direct comparison of HMV and non-HMV iso-
lates. Recently, isolates recovered from African Green 
monkeys (AGM) presenting with a HMV phenotype, 
and belonging to serotype K1 and K5 were found to be 
significantly more virulent and resistant than non-HMV 
isolates in in vitro, serum, and oxidative-mediated killing 
assays [17].
To gain a better understanding about the pathogen-
esis of this important emergent disease in primates, and 
to investigate the role of innate and adaptive immune 
components in the protection against K. pneumoniae, 
we evaluated the role of complement and antibody in 
protection against HMV and non-HMV isolates using 
the AGM. An understanding of the relevant protective 
immune mechanisms against klebsiellosis is essential if a 
vaccine is to be developed in a timely manner.
Materials and methods
Animal subjects and inclusion criteria
Both the Ross University School of Veterinary Medicine 
and Behavioural Science Foundation Institutional Animal 
Care and Use Committees reviewed and approved this 
study. In order to assess prior exposure or current infec-
tion (clinical or sub-clinical) of K. pneumoniae, 25 female 
captive AGM, ages 5–10 years old from the Behavioural 
Science Foundation, St. Kitts, were screened serologically 
and molecularly following protocols by Cox et  al. [17] 
(Table 2).
In order to collect blood and swabs from the AGM, ani-
mals were isolated by tunneling into a squeeze cage and 
anesthetized with ketamine (10  mg/kg intramuscular) 
and brought to a central husbandry area for examination 
by a veterinarian. All of these animals were confirmed 
as healthy on physical examination. Depending on the 
experiment, whole blood (4–6 mL/animal) was collected 
from the femoral vein using red top, EDTA or sodium 
heparin vacutainer tubes (Becton Dickinson and Com-
pany, Sparks, MD, USA), and placed on ice. Six animals 
(three seropositive and three seronegative donors) were 
chosen for further investigation. They were bled three 
additional times giving them at least 2  weeks between 
sample collections. Animals recovered from anesthesia 
in their home cages or tunnels of their home cages. They 
were kept sheltered and under observation until com-
pletely recovered.
Nasal, vaginal, fecal and oral swabs were collected from 
the AGM and suspended in 500 μL PBS and total DNA 
was extracted utilizing, the DNeasy Kit (nasal, vaginal 
and oral) or the QIAamp DNA Stool Mini Kit (fecal) 
(Qiagen, Valencia, CA, USA). Extracted DNA served as 
a template in a real-time PCR assay for the detection of 
the K. pneumoniae khe, rpmA, or magA genes (Table 2) 
following published protocols [18]. Blood collected from 
donor animals was subjected to complete blood counts 
and biochemical analysis of plasma using Abaxis HM5c 
Hematology Analyzer and Abaxis VetScan VS2 (Abaxis 
North America, Union City, CA, USA). Additionally, 
protein electrophoresis analysis of serum was performed 
at Kansas State University Veterinary Diagnostic Labo-
ratory using the TITAN GEL Serum Protein System 
(Helena Laboratories, Beaumont, TX, USA).
Bacterial strains and culture conditions
Klebsiella pneumoniae strains cultured from AGM with 
single or multifocal abscesses were isolated at the Ross 
University School of Veterinary Medicine Diagnostic 
Laboratory from 2010 to 2012. Identification and charac-
terization of the isolates was made according to standard 
clinical microbiologic and molecular methods (Table  1) 
[6, 17, 18]. For general use, K. pneumoniae was grown on 
5% sheep blood agar plates, brain–heart infusion broth 
(BHI) or Luria–Bertani (LB) broth (Sigma-Aldrich, St. 
Louis, MO, USA) at 37 °C. The mucoviscosity levels were 
determined by string test and centrifugation (Table  1) 
[19, 20]. Briefly, K. pneumoniae isolates were cultivated at 
37 °C overnight. The following morning 1.2 mL of optical 
density (OD)600 normalized bacteria grown in LB broth 
was centrifuged in microcentrifuge tubes at 2000  g for 
5 min. The absorbance of the supernatant was measured 
at OD600. A representative K1, K5 and non-HMV isolate 
previously characterized were used for in vitro challenges 
[17].
Serologic assays for anti‑K. pneumoniae immunoglobulins
Indirect ELISA was used to determine AGM IgG and 
IgM antibody concentrations against HMV and non-
HMV-K. pneumoniae in serum from seropositive and 
seronegative donors. Protocols described by Cox et  al. 
[17] were followed with modifications. Briefly, BD Fal-
con 96-well black/clear flat-bottom microtitre plates 
(Becton Dickinson and Company, Sparks, MD, USA) 
were coated with 5 × 106 colony forming units (CFU) per 
well live K. pneumoniae in carbonate coating buffer, pH 
9.6, at 100 µL per well, and incubated overnight at 4 °C. 
Plates were washed three times in PBS containing 0.05% 
Tween-20 (PBST), and blocked for 1 h at room tempera-
ture (RT) with ELISA Blocking Buffer (Sigma-Aldrich, 
St. Louis, MO, USA). Serum samples were diluted 1:50 
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in PBST. Negative control wells were incubated with 
PBST alone. Plates were incubated overnight at 4 °C and 
washed 5× with PBST. Rabbit polyclonal to Human IgG-
FITC, or Rabbit Anti-Human IgM H&L-FITC secondary 
antibodies (Abcam, Cambridge, MA, USA) were diluted 
in PBST following manufacturer recommendations, and 
100 µL were added to each well. After incubation at room 
temperature for 2 h, the plate was washed 5× with PBST 
before adding 100 µL of PBST. Fluorescence at excitation 
of 493  nm and emission of 528  nm was recorded using 
the Infinite M200 96-well-plate reader (Tecan Group 
Ltd., Mannedorf, Switzerland).
Quantification of IgG sub-types in donor samples was 
performed using PeliClass human IgG subclass kit fol-
lowing manufacturer’s instructions (Sanquin Reagents, 
Amsterdam, The Netherlands).
Serologic assays for K. pneumoniae complement 
deposition
Indirect ELISA was used to compare complement C3/
C3b and C5–9 (membrane attack complex) deposition 
on K. pneumoniae using serum from seropositive and 
seronegative donors. Protocols described by Cox et  al. 
[17] were followed with modifications. Seeding of antigen 
was done as previously described. After overnight incu-
bation at 4 °C, wells were washed 5× with PBST. Mouse 
monoclonal to C3/C3b, or Mouse monoclonal to C5b-9 
secondary antibody (Abcam, Cambridge, MA, USA) 
were diluted in PBST following manufacturer recom-
mendations, and 100 µL were added to each well. Plates 
were incubated at RT for 2  h, followed by 5× washes 
with PBST before adding Rat monoclonal to IgG2a HRP 
(Abcam) as tertiary antibody. After incubation at 25  °C 
for 1 h, the plate was washed 5× with PBST before add-
ing 100  µL of ABTS Peroxidase Substrate (KPL, Gaith-
ersburg, MD, USA) to each well. The ELISA reaction was 
stopped after 30  min with 100  µL 1% sodium dodecyl 
sulfate, and the optical density (OD) of the reactions was 
read at 405 nm with a SpectraMax M2/M2e Microplate 
Reader (Molecular Devices, Sunnyvale, CA, USA).
Klebsiella serum and whole blood killing assays
Whole blood and serum bactericidal assays developed 
by MacLennan et  al. [21] were modified to investigate 
in vitro killing of serum sensitive E. coli, HMV and non-
HMV K. pneumoniae isolates. Blood or serum from 
three seropositive and three seronegative donors was 
used (Table  2). Killing of different bacterial isolates was 
assessed using (a) heparinized blood (4  IU/mL sodium 
heparin) within 2 h of venesection; (b) serum separated 
within 2  h and stored at –80  °C; (c) heat inactivated 
serum (inactivated by heating serum to 56 °C for 30 min); 
or (d) blood-cell-suspensions, prepared by washing blood 
twice with Roswell Park Memorial Institute (RPMI)-1640 
medium (Gibco by Life Technologies, Grand Island, NY, 
USA) to remove antibody and complement before resus-
pending in RPMI to the original blood volume (whole 
blood-RPMI). Viable bacteria (2 × 105 in 20  μL), were 
added to 180 μL of 100% whole blood, undiluted serum 
(normal and heat-inactivated), or blood-cell-suspensions 
to give a final bacterial concentration of 1 × 106/mL 
regardless of white cell count. These mixtures were then 
incubated at 37 °C on a rocker plate at 20 rpm. Numbers 
of viable bacteria were determined after 60 min by serial 
dilution of 20  μL of the mixture plated in triplicate on 
blood agar plates.
Phagocytosis by peripheral blood mononuclear 
and polymorphonuclear leukocytes assays
Within 1  h of collection, peripheral blood mononuclear 
cells (PBMC) and polymorphonuclear leukocytes (PMNL) 
were purified from blood collected in EDTA using Histo-
paque 1077 (Sigma-Aldrich, St. Louis, MO, USA) follow-
ing manufacturer’s instructions and published protocols 
Table 1 Klebsiella pneumoniae isolates used in this study
AGM: African green monkey, ND: not determined.
a Done as described in [19, 20].
b Done as described in [18].



















AGM Positive (+++) Positive Positive Positive K1
K5 Klebsiella
 pneumoniae
AGM Positive (++) Positive Positive Negative K5
NHM Klebsiella
 pneumoniae
AGM Negative Positive Negative Negative ND
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[17]. Erythrocytes were removed by hypotonic lysis in 
water for 30  s and isotonic conditions restored immedi-
ately by adding an equal volume of 2 ×  PBS. Thereafter 
the PMNL were washed twice in PBS and collected by low 
speed centrifugation. Viability of PMNL and PBMC was 
verified using trypan blue exclusion assays. PMNL and 
PBMC were plated at a concentration 1 × 106 per well in 
24-well tissue culture plates (Becton Dickinson and Com-
pany, Sparks, MD, USA). After a 2 h incubation at 37 °C, 
cells were challenged with a suspension of bacteria in cell 
culture medium containing 10% serum (normal or heat 
inactivated from seropositive or seronegative donors) 
to obtain an multiplicity of infection (MOI) of 1:20 (leu-
kocyte to bacteria). One hour post-incubation, wells 
were washed with PBS and incubated for 1 h with fresh 
medium containing gentamicin (100  µg/mL) (Sigma-
Aldrich, St. Louis, MO, USA) to kill extracellular bacte-
ria, followed by three washes with PBS, and later lysis by 
incubation in PBS supplemented with 0.5% Triton X-100 
(Sigma-Aldrich). Internalized bacteria were quantified by 
plating appropriate dilutions on agar plates.
Oxidative burst assay
The Bursttest assay (Becton Dickinson) and protocols by 
Gondwe et al. [22] and Lin et al. [23] were used to meas-
ure oxidative burst activity in AGM PMNL and PBMC by 
flow cytometry by determining oxidation of dihydrorho-
damine to rhodamine. Opsonization was by incubating 
109/mL of heat-killed K. pneumoniae in serum obtained 
from seropositive and seronegative donors for 1  h at 
room temperature at a ratio of 1:10. RPMI washed cells 
were stimulated with opsonized heat-killed K. pneumo-
niae at 2 × 108/mL for 10 and 60 min at 37 °C according 
to the manufacturer’s instructions before incubating with 
dihydrorhodamine. Following red cell lysis and fixation, 
leukocytes were analyzed on a FACSCalibur flow cytom-
eter (Becton Dickinson). PMNL and PBMC were gated 
according to light scatter characteristics. Rhodamine 
fluoresces in the FL1 channel and oxidative burst activ-
ity was measured according to the manufacturer’s 
instructions as geometric mean fluorescence intensity 
from the FL1 histogram (arbitrary units). Controls con-
sisted of PMA, fMLP, pre-opsonized E. coli and TLR-2 
(PAM3CSK4) stimulation.
Statistical analysis
The SAS® (version 9.4, SAS Institute, Cary, NC, USA) 
GLM procedure was used to conduct an analysis of vari-
ance in a factorial arrangement of treatments. When 
overall significance was found post hoc comparisons 
were conducted with pairwise t tests of least-squares 
means. All tests were considered significant at p ≤ 0.05.
Serum and whole blood killing assays
Effects in the model included isolate (K1, K5, NHM, E. 
coli), treatment (whole blood cells, whole blood-RPMI, 
normal serum, heat-inactivated serum) and titer of donor 
(seropositive or seronegative) and the two-way and three-
way interactions.
AGM PMNL and PBMC uptake of Klebsiella pneumoniae
Effects in the model included isolate (K1, K5, NHM), 
treatment (normal serum, heat-inactivated serum) and 
titer of donor (seropositive or seronegative) and the two-
way and three-way interactions.
Immonuglobulin IgG and IgM and complelement proteins C3/
C3b and C5‑9 binding to Klebsiella pneumoniae
Effects in the model included isolate (K1, K5, NHM), and 
titer of donor (seropositive or seronegative) and the two-
way interaction.
Immonuglobulin IgG subtype quantification in serum 
from seropositive and seronegative AGM donors
Two-sample t tests assuming equal variance were used to 
statistically compare IgG1, IgG2, IgG3 and IgG4 levels in 
Table 2 Inclusion criteria for African Green monkey donors in this study
a According to [17].
b According to [18].
Donor Age (years) Sex Anti‑Klebsiella pneumoniae IgG titersa Isolation of K. pneumoniae or detection of khe, 
rmpA or magA related genesb
Donor des‑
ignation
Female K1 K5 Non‑HMV Fecal Oral Vaginal Nasal
1 11 Female 8192 8192 8192 – – – – Seropositive
2 5 Female 8192 8192 2048 – – – – Seropositive
3 5 Female 16 384 8192 8192 – – – – Seropositive
4 5 Female 1024 1024 1024 – – – – Seronegative
5 5 Female 512 256 512 – – – – Seronegative
6 6 Female 1024 1024 1024 – – – – Seronegative
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seropositive and seronegative donors. P ≤ 0.05 was con-
sidered significant.
Results
Serologic and molecular diagnosis of klebsiellosis 
in African green monkey donors
Real-time amplification of oral, nasal, vaginal and fecal 
swab material did not detect the khe, magA, or rmpA 
gene in any of the sampled monkeys. Three animals 
were classified as seropositive donors based on IgG 
titers  >8192 against K. pneumoniae isolates K1 and K5 
(Table  2; Figure  1). On the other hand, three seronega-
tive donors were included presenting IgG titres of ≤ 1024 
(Table 2; Figure 1). Similar amounts of anti-K. pneumo-
niae K1 and K5 IgM were detected in seropositive and 
seronegative donors (Figure  1). Significantly greater 
amount of anti-K. pneumoniae IgG and IgM binding to 
non-HMV isolates was detected when compared to those 
binding to K1 or K5 isolates. Complete blood counts, 
serum clinical chemistries, and protein electrophoresis 
of serum resulted in similar values between seropositive 
and seronegative donors (data not shown).
IgG quantification in donor monkeys
Concentrations of IgG1, IgG3 and IgG4 were similar in 
seropositive and seronegative donors (p < 0.05); however, 
levels of IgG2 antibodies were significantly lower in the 
seropositive donors (p = 0.004) (Figure 2).
Complement binding to opsonized K. pneumoniae
Greater binding of C3/C3b to K1 and K5  K. pneumo-
niae was found in serum from seropositive donors than 
in serum from seronegative donors (p < 0.05) (Figure 3). 
There was similar binding of C3/C3b to NHM, K1 and 
K5 isolates (p  >  0.05). Additionally, similar binding of 
C5–9 was detected when using serum of seropositive and 
seronegative donors, and in NHM, K1 and K5 isolates 
(p > 0.05) (Figure 3).
Blood and serum killing of K. pneumoniae isolates
Similar survival was detected in serum-sensitive E. coli, 
NHM, K1 and K5  K. pneumoniae isolates when incu-
bated in heat-inactivated serum from seropositive and 
seronegative donors (p  >  0.05) (Figure  4A). There was 
100% survival in all treatments. K1 and K5  K. pneumo-
niae presented significantly greater survival than non-
HMV isolates when challenged with normal serum 
collected from seropositive and seronegative donors 
(p < 0.05) (Figure 4B). Although not significant (p > 0.05), 
there was greater survival of K1 and K5 K. pneumoniae 
isolates in normal serum from seropositive, as com-
pared to seronegative donors. No difference in survival 
Figure 1 Indirect ELISA demonstrating antibody binding to Klebsiella pneumoniae. Binding of IgG (A, B and C) and IgM (D, E, F) to 
hypermucoviscous isolates K1 (A and D, black bars), K5 (B and E, diagonal lines) and non- hypermucoviscous (NHM) (C and F, white bars) Klebsiella 
pneumoniae using serum obtained from seropositive and seronegative African green was measured using the Infinite M200 96-well-plate reader 
(Tecan Group Ltd., Mannedorf, Switzerland). Fluorescence was recorded at excitation of 493 nm and emission of 528 nm. The error bars represent 
standard errors for triplicate samples, and the results shown are representative of three independent experiments. The error bars represent standard 
errors for triplicate samples, and the results shown are representative of three independent experiments. Asterisk indicates significant difference 
between treatments, p ≤ 0.05; Double asterisk indicates significant difference between treatments, p ≤ 0.001; Equal to indicates similarity between 
treatments, p > 0.05.
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Figure 2 Quantification of IgG sub-types in serum obtained from seropositive and seronegative African green monkey donors. 
IgG1 (A), IgG2 (B), IgG3 (C) and IgG4 (D) in donor serum were quantified using PeliClass human IgG subclass kit following manufacturer’s instruc-
tions (Sanquin Reagents, Amsterdam, The Netherlands). Optical density of the reactions was read with a SpectraMax M2/M2e Microplate Reader 
(Molecular Devices, Sunnyvale, CA, USA). The error bars represent standard errors for triplicate samples, and the results shown are representative of 
three independent experiments. The error bars represent standard errors for triplicate samples, and the results shown are representative of three 
independent experiments. Asterisk indicates significant difference between treatments, p ≤ 0.05; Double asterisk indicates significant difference 
between treatments, p ≤ 0.001; Equal to indicates similarity between treatments, p > 0.05.
Figure 3 Indirect ELISA demonstrating complement binding to Klebsiella pneumoniae. Binding of C3/C3b (A, B and C) and C5–9 (D, E and 
F) to hypermucoviscous isolates K1 (A and D, black bars), K5 (B and E, diagonal lines), and non- hypermucoviscous (NHM) (C and F, white bars) Kleb-
siella pneumoniae using serum obtained from seropositive and seronegative African green monkey was estimated by optical density measured with 
a SpectraMax M2/M2e Microplate Reader (Molecular Devices, Sunnyvale, CA, USA). The error bars represent standard errors for triplicate samples, 
and the results shown are representative of three independent experiments. Asterisk indicates significant difference between treatments, p ≤ 0.05; 
Double asterisk indicates significant difference between treatments, p ≤ 0.001; Equal to indicates similarity between treatments, p > 0.05.
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was detected between K1 and K5 K. pneumoniae isolates 
(p > 0.05). Additionally, E. coli was significantly more sus-
ceptible than HMV and non-HMV K. pneumoniae iso-
lates (p < 0.05) (Figure 4B).
When incubated in whole blood-RPMI collected 
from seropositive or seronegative donors, similar sur-
vival was detected in NHM, K1 and K5 K. pneumoniae 
(p > 0.05); however, all serum-sensitive E. coli were killed 
(Figure 5A). Significantly greater survival of K1, K5 and 
NHM K. pneumoniae isolates was detected after incu-
bation in heparinized blood from seropositive donors 
as compared to that from seronegative donors (p < 0.05) 
(Figure 5B). Significantly greater survival was detected in 
HMV isolates (K1 and K5) than in non-HMV K. pneumo-
niae isolates (p < 0.05). All E. coli was killed (Figure 5B).
Uptake of opsonized K. pneumoniae by AGM leukocytes
AGM PMBC and PMNL phagocytized significantly 
greater amounts of K1, K5 and NHM K. pneumoniae 
when complement was active (p < 0.05) (Figures 6, 7, 8). 
Similar numbers of K5 and NHM K. pneumoniae were 
taken up by AGM PMBC and PMNL when opsonized 
with normal serum from seropositive and seronega-
tive donors (Figures  6, 7, 8); however, significantly 
greater amounts of K1 were taken up by AGM PMBC 
when opsonized with normal serum from seronegative 
donors. Significantly lower amounts of K1 were taken up 
by PMNL when compared to other isolates, even in the 
presence of normal serum (p < 0.05) (Figures 6, 7, 8).
No oxidative burst activity in AGM PMNL and PBMC 
was detected after challenge with K. pneumoniae pre-
viously opsonized with normal serum or heat inacti-
vated-serum from seropositive and seronegative donors. 
Stimulation of oxidative burst activity in AGM PMNL 
and PBMC with PMA, fMLP, pre-opsonized E. coli and 
TLR-2 (PAM3CSK4) resulted in positive detection when 
using the modified protocols of Gondwe et al. [22], using 
the PHAGOBURST kit (data not shown).
Discussion
The components of the innate immune system, includ-
ing humoral elements like complement, and cellular 
elements like PMNL and PBMC are critical to protect 
the host upon bacterial infection. Additionally, there is 
evidence of a role for both bactericidal and opsonizing 
antibody in immunity to members of the family Entero-
bactericeae [21, 22, 24]. On the other hand, bacterial 
pathogens acquire and employ different virulence fac-
tors upon contact with innate and adaptive immune sys-
tem of the host to ensure colonization and dissemination 
within the host. Some of the best characterized virulence 
determinants of K. pneumoniae are the capsule, lipopoly-
saccharides, siderophores, and types 1 and 3 fimbriae 
[25]. As with other Gram-negative bacteria, the capsule 
Figure 4 Serum-mediated killing of isolates K1, K5 and non- hypermucoviscous (NHM) Klebsiella pneumoniae and Escherichia coli. 
LOG CFU/mL of bacteria 1 h post-incubation in heat-inactivated serum (A) or normal serum (B) recovered from seronegative (dark bars) or seroposi-
tive (clear bars) African Green monkey. The error bars represent standard errors for triplicate samples, and the results shown are representative of 
three independent experiments. The error bars represent standard errors for triplicate samples, and the results shown are representative of three 
independent experiments. Asterisk indicates significant difference between treatments, p ≤ 0.05; Double asterisk indicates significant difference 
between treatments, p ≤ 0.001; Equal to indicates similarity between treatments, p > 0.05.
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is associated with attachment to host receptors, protec-
tion from phagocytosis, and with barrier function against 
innate host defense components such as complement, 
lysozyme, and oxidative mediated killing [26]. Distinct 
capsular components and an increased amount of capsu-
lar material in HMV K. pneumoniae have been described 
in hypervirulent K. pneumoniae human isolates [10]. 
However, little work elucidating the role of the HMV 
phenotype in K. pneumoniae pathogenicity exists, and no 
direct comparison of HMV and non-HMV isolates using 
components of the innate and adaptive immune system 
of naturally susceptible hosts has been performed. Here 
we examined the potential role of antibody and com-
plement in the control of K. pneumoniae using in  vitro 
assays. African green monkeys are not only extremely 
important animals in biomedical research, but also are 
naturally susceptible to K. pneumoniae infections. Due 
to their close phylogenetic relationship to humans, they 
are recognized as an intermediate animal model between 
humans and rodents, and are an indispensable model for 
human diseases [27, 28].
The role of complement and antibodies and its interac-
tion in conferring protection against klebsiellosis appears 
complex, particularly for HMV K. pneumoniae. In this 
study, HMV isolates (K1 and K5) were found to be resist-
ant to complement-mediated killing as indicated by AGM 
serum and whole blood killing assays (Figures 4  and 5). 
Non-HMV isolates were at least partially susceptible to 
its effect as the removal of killing was observed in serum 
with heat inactivation of complement (Figures 4 and 5). 
Isolates K1 and K5 produced a significantly more mucoid 
capsule, than isolates designated non-HMV strains, and 
K1 was found more mucoid than K5 serotypes (p < 0.05) 
(Figure  9; Table  1). The biological significance of the 
greater mucoviscosity found in HMV K1 isolates when 
compared to HMV K5 isolates is unknown. The amount 
of capsular polysaccharides produced by K. pneumoniae 
is suspected to be significantly more important for resist-
ance against complement than its chemical composi-
tion [29]; and together with lipopolysaccharide (LPS), 
these two virulence factors appear as major mechanisms 
of resistance to the bactericidal activity of complement 
[29–31]. Our results indicate similar resistance to com-
plement by K1 and K5 HMV isolates (Figures  4  and 5); 
however, K5 were phagocytized by PBMC and PMNL) 
in greater amounts than K1 isolates in the presence of 
normal serum (p = 0.0006 and p = 0.0020, respectively) 
(Figures 6 and 7). Similar findings were reported by Cox 
et  al. [17] were khe+, rmpA+, magA− isolates associ-
ated with the AGM PBMC to a greater extent than khe+, 
rmpA+, magA+), isolates (p < 0.05).
The complement system is an important component 
of innate immunity that consist of a cascade of soluble 
proteins and membrane-expressed receptors and regula-
tors, which operates in plasma, tissues, cell surfaces and 
even within the cell. Complement (C3) activation can 
proceed via three enzymatic cascades, the classical, the 
alternative, and the mannose-binding lectin (MBL) path-
ways. The classical complement pathway is initiated by 
the binding of C1q to the Fc portion of antibody–antigen 
Figure 5 Whole blood-mediated killing of isolates K1, K5 and non- hypermucoviscous (NHM) Klebsiella pneumoniae and Escherichia 
coli. LOG CFU/mL of bacteria 1 h post-incubation in RPMI washed whole blood (A) or heparinized-whole blood (B) recovered from seronegative 
(dark bars) or seropositive (clear bars) African Green monkey. The error bars represent standard errors for triplicate samples, and the results shown 
are representative of three independent experiments. Treatments with different letters are significantly different from one another at p < 0.05. Aster-
isk indicates significant difference between treatments, p ≤ 0.05; Double asterisk indicates significant difference between treatments, p ≤ 0.001; 
Equal to indicates similarity between treatments, p > 0.05.
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complexes on the bacterial surface, while the alternative 
and lectin pathways are activated by cell surface compo-
nents of bacteria. Activation of any of these three path-
ways leads to the opsonization of the target with the 
complement component C3b. Formation of C3b by a 
set of programmed enzymatic reactions proceeds to the 
assembly of a membrane attack complex (MAC) and bac-
teriolysis. It also plays a central role in the inflammatory 
process and modulates the activity of T- and B-cells. In 
addition, the complement receptors present on phago-
cytes bind C3b and iC3b molecules on the bacteria to 
induce phagocytosis [24, 32]. Similar binding of C3/C3b 
and C5–9 was detected in NHM, K1 and K5 isolates 
(Figure  3); however as already mentioned, greater sus-
ceptibility to complement-mediated killing was found 
in NHM strains. Serum-resistant K. pneumoniae have a 
reduced ability to bind C1q, and this results in comple-
ment activation by serum-resistant strains principally via 
the alternative pathway; however serum-sensitive strains 
activate both the alternative and classical pathways, 
resulting in greater deposition of C3b and subsequent 
killing by the membrane attack complex [33, 34]. In this 
study, complement C3/C3b binding to K. pneumoniae 
was significantly greater when serum from seropositive 
donors was used (p  <  0.05), and although not signifi-
cantly different, there was slightly greater binding of C5-9 
in serum from seropositive donors (Figure  3). However, 
whole blood and serum killing assays indicate greater 
survival of K. pneumoniae in the presence of normal 
serum from seropositive donors when compared with 
normal serum from seronegative animals. Therefore a 
distinct correlation between complement deposition and 
Figure 6 Peripheral blood mononuclear cells (PBMC) uptake of Klebsiella pneumoniae. Uptake of opsonized K1, K5, and non-HMV K. 
pneumoniae with normal serum (A and B) or heat-inactivated serum (C and D) from seropositive (A and C) or seronegative (B and D) donors by 
African Green monkey (AGM) PBMC was measured in vitro as described. The results are expressed as fold-uptake when compared to PBS opsonized 
bacteria. The error bars represent standard errors for triplicate samples, and the results shown are representative of three independent experi-
ments. Asterisk indicates significant difference between treatments, p ≤ 0.05; Double asterisk indicates significant difference between treatments, 
p ≤ 0.001; Equal to indicates similarity between treatments, p > 0.05.
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IgG titer supporting antibody-dependent complement-
mediated killing as the mechanism of bactericidal activ-
ity was not found (Figures  4 and 5). In contrast to our 
findings, Yeh et al. [35] reported that K1 and K2 HMV K. 
pneumoniae isolates recovered from liver abscess showed 
resistance to serum from normal human patients, but 
were significantly more susceptible to killing effects of 
serum when incubated with serum from patients with 
recurrent K1 K. pneumoniae liver abscesses. However, a 
direct comparison to Yeh et al. [35] findings is not possi-
ble since it is unknown if our serum donors had mounted 
an antibody response to K. pnemoniae from sub-clinical, 
clinical or recurrent infection. In some cases, bacte-
ria can resist complement-mediated killing by immune 
serum, and this phenomenon has been reported in other 
members of the family Enterobactericeae like Salmonella 
enterica, and other Gram-negative and Gram-positive 
pathogens [21, 22, 36, 37].
The role of anti-Klebisella antibodies as opsonins was 
also explored using AGM PBMC and PMNL in in  vitro 
uptake assays. In these experiments, there was greater 
uptake of bacteria by PMNL and macrophages when 
bacteria was opsonized with normal serum, indicating a 
role of complement in opsonization (Figure 8); however 
the greater amount of IgG on groups designated as “sero-
positive donors” did not appear to be protective, and as 
indicated by whole blood killing assays, incubation in 
heparinized blood from seronegative donors resulted in 
significantly less survival of HMV and non-HMV iso-
lates (p  <  0.05). Additionally, no oxidative burst activ-
ity was detected in PMNL and PBMC incubated with 
opsonized bacteria. Similar results have been reported 
in human PMNL stimulated with K. pneumoniae sero-
type K1, K2, K4 and K5 [11, 38] Further work by Sahly 
et  al. [39] identified that the lower response of respira-
tory burst in human PMNL produced by some K. pneu-
moniae could be associated with lack of manno(rhamno)
biose in the capsular polysaccharides of this bacteria. 
Thus, although complement increased opsonization of 
all K. pneumoniae (Figure  8); HMV isolates appear to 
Figure 7 Polymorphonuclear leukocytes (PMNL) uptake of Klebsiella pneumoniae. Uptake of opsonized K1, K5, and non-HMV K. pneumo-
niae with normal serum (A and B) or heat-inactivated serum (C and D) from seropositive (A and C) or seronegative (B and D) donors by African 
Green monkey (AGM) PMNL was measured in vitro as described. The results are expressed as fold-uptake when compared to PBS opsonized 
bacteria. The error bars represent standard errors for triplicate samples, and the results shown are representative of three independent experi-
ments. Asterisk indicates significant difference between treatments, p ≤ 0.05; Double asterisk indicates significant difference between treatments, 
p ≤ 0.001; Equal to indicates similarity between treatments, p > 0.05.
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be resistant to killing even in presence of active comple-
ment and IgG and IgM. In S. enterica, there is a critical 
requirement for complement in opsonization and killing, 
as bacterium opsonization by antibodies alone results in 
negligible phagocytosis, oxidative burst and cellular kill-
ing by human peripheral blood cells [22]. In this study, 
significantly greater amounts of IgM were found bind-
ing to non-HMV isolates than to K1 and K5 isolates 
(Figure 1); thus IgM could be at least partially associated 
with greater protection at least against non-HMV iso-
lates as indicated by greater susceptibility of non-HMV 
isolates in serum and whole blood killing. IgM has been 
shown to have more ability to activate complement on S. 
enterica than IgG [40]. The significantly greater amount 
of capsule present in HMV isolates K1 and K5 could be 
associated with complement mediated killing resistance 
in these isolates.
Immunoglobulin G is the most abundant immuno-
globulin in primate serum. There are at least four dif-
ferent subclasses of IgG, and although they are highly 
conserved, they differ in their constant region, and have 
different effector functions [41]. It was interesting to find 
that seropositive donors had at least a partial deficiency 
in IgG2 (Figure  2). IgG2 deficiencies have been associ-
ated with increased susceptibility to certain bacterial 
infections [41]; and Alsaedi et  al. [42] recently reported 
IgG2 deficiency and low IgM in a human patient present-
ing recurrent HMV K. pneumoniae bacteremia in the 
absence of pyogenic liver abscess or other localized meta-
static Klebsiella infection.
Figure 8 Role of complement and antibodies as opsonins of Klebsiella pneumoniae in in vitro assays. Uptake of hypermucoviscous K1 
(A and D, black bars), K5 (B and E, diagonal bars), and non-HMV K. pneumoniae (C and F, white bars) by African Green monkey (AGM) peripheral 
blood mononuclear cells (PBMC) (A, B and C) or polymorphonuclear leukocytes (PMNL) (D, E and F) was determined as described. The results are 
expressed as fold-uptake of opsonized bacteria with normal serum from seropositive (Positive/NS) or seronegative (Negative/NS) donors, or heat-
inactivated serum from seropositive (Positive/HI) or seronegative (Negative/HI) donors when compared to PBS opsonized bacteria. The error bars 
represent standard errors for triplicate samples, and the results shown are representative of three independent experiments. Asterisk indicates sig-
nificant difference between treatments, p ≤ 0.05; Double asterisk indicates significant difference between treatments, p ≤ 0.001; Equal to indicates 
similarity between treatments, p > 0.05.
Figure 9 Klebsiella pneumoniae mucoviscosity levels. 
Mucoviscosity of hypermucoviscous isolates K1, K5 and non-hyper-
mucoviscous (NHM) was evaluated measuring optical density (OD)600 
of normalized bacteria grown in LB broth after centrifugation. The 
error bars represent standard errors for triplicate samples, and the 
results shown are representative of three independent experiments. 
Asterisk indicates significant difference between treatments, p ≤ 0.05; 
Double asterisk indicates significant difference between treatments, 
p ≤ 0.001; Equal to indicates similarity between treatments.
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A major limitation in this study was the low num-
ber of seropositive and seronegative AGM donors. In 
the future, a better understanding on the recurrence of 
K. pneumoniae in non-human primates and other ani-
mals, and complete characterization of immunogens 
recognized by the host could be use to investigate the 
protective capacity of specific immunoglobulins to kleb-
siellosis. This can result in novel vaccines for humans 
and animals. In previous work, K1 K. pneumoniae iso-
lates that were opsonized with serum from patients with 
recurrent K1 K. pneumoniae liver abscesses presented a 
significant increase in PMNL phagocytosis, compared 
to rates in K1 bacteria opsonized with serum from nor-
mal patients [35]; thus it appears that primates are able 
to mount protective immunity to HMV isolates. Wu 
et  al. [43] reported that anti-capsular polysaccharide 
monoclonal antibodies agglutinate different strains of K. 
pneumoniae, including K1 serotype, enhanced phago-
cytosis by human monocyte-derived macrophages and 
protected mice in laboratory controlled in  vivo chal-
lenges with magA+ K. pneumoniae. Potential use of live-
attenuated strains as vaccines has also been explored. 
Hsieh et  al. [44] mutated O1:K1 and O1:K2 mutants 
deleting the O1 synthesizing genes and attenuated the 
strains as demonstrated in serum killing assays. Moreo-
ver, immunization of mice with a magA-mutant (K1−O1) 
against LPS O1 provided protection against infection 
with an O1:K2 strain, but not against infection with 
an O1:K1 strain. [44] Cleary, more research investigat-
ing the host-pathogen interaction of hypervirulent and 
HMV strains with different in vivo and in vitro models 
are needed to better understand the pathogenesis of this 
emergent pathogen and to develop efficacious vaccines 
for humans and other animals.
Our findings highlight the complexity of the non-
human primate immune response to HMV isolates of K. 
pneumoniae. These isolates evaded important compo-
nents of the AGM innate and adaptive immune system, 
including serum- mediated killing, PBMC and PMNL 
phagocytosis and respiratory burst. Deeper understand-
ing of the pathophysiology of infection with HMV K. 
pnemoniae related to virulence, resistance, and predis-
posing AGM host factors is required.
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